News tagged with cancer inhibitor
Soybeans soaked in warm water naturally release key cancer-fighting substance
Soybeans soaking in warm water could become a new "green" source for production of a cancer-fighting substance now manufactured in a complicated and time-consuming industrial process, scientists are reporting ...
May 09, 2012 |
5 / 5 (4) |
1
New inhibitors of a cancer-causing protein may lead to targeted therapeutics
(PhysOrg.com) -- Markus Seeliger, Ph.D., Assistant Professor, Department of Pharmacological Sciences, Stony Brook University School of Medicine, and collaborators at Harvard University, have developed and ...
Mar 29, 2012 |
5 / 5 (4) |
0
|
Mapping of protein inhibitors facilitates development of tailor-made anticancer agents
(PhysOrg.com) -- A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism ...
Feb 20, 2012 |
5 / 5 (3) |
0
|
Four new leads identified for anti-cancer drugs
Four new anti-cancer drug leads have been identified in a research paper published online this week in Bioorganic and Medicinal Chemistry.
Nov 28, 2011 |
not rated yet |
1
First-of-its-kind study creates new tool for targeted cancer drug development
In a technical tour de force, scientists at Fox Chase Cancer Center have cataloged and cross-indexed the actions of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes critical ...
Oct 30, 2011 |
not rated yet |
0
|
US regulators approve new hepatitis C drug
US regulators on Friday approved the first new treatment for hepatitis C in more than a decade, a Merck pharmaceutical known as Victrelis, to be taken with the current two-drug regimen.
Medicine & Health / Medications
May 14, 2011 |
not rated yet |
2
US panel gives nod to Merck hepatitis C drug
A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.
Medicine & Health / Medications
Apr 27, 2011 |
5 / 5 (1) |
0
New approach to leukemia chemotherapy -- is a cure in sight?
Speaking at the UK National Stem Cell Network conference in York later today (31 March), Professor Tessa Holyoake from the University of Glasgow will discuss a brand new approach to treating chronic myeloid leukaemia (CML) ...
Mar 31, 2011 |
not rated yet |
0
Study reveals how lung cancers evolve in response to targeted treatment
A detailed analysis of lung tumors that became resistant to targeted therapy drugs has revealed two previously unreported resistance mechanisms. In a report in the March 23 Science Translational Medicine, investigators from t ...
Mar 23, 2011 |
not rated yet |
0
Purdue startup hopes to change the way we test cancer drugs
A Purdue University scientist's nanopolymer would make it easier and cheaper for drug developers to test the effectiveness of a widely used class of cancer inhibitors.
Chemistry / Analytical Chemistry
Mar 16, 2011 |
not rated yet |
0
Combining two peptide inhibitors might block tumor growth
A new study suggests that combining two experimental anticancer peptide agents might simultaneously block formation of new tumor blood vessels while also inhibiting the growth of tumor cells.
Mar 14, 2011 |
5 / 5 (2) |
0
|
Hit multiple targets for maximum benefit in HER2-positive breast cancer, studies suggest
Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators.
Mar 08, 2011 |
not rated yet |
0
|
Popular drugs for common male health problems can affect their sexual health
A new study published in The Journal of Sexual Medicine reveals that, for the first time, 5a-reductase inhibitors commonly used to treat urinary problems in patients with benign prostatic hyperplasia (BPH) and found in pop ...
Medicine & Health / Medications
Mar 07, 2011 |
not rated yet |
0
Depression drug may relieve pain from breast cancer treatment, study finds
A drug commonly used to treat depression and anxiety disorder was effective at reducing joint and muscle pain associated with a breast cancer treatment, according to a study from the University of Michigan Comprehensive Cancer ...
Dec 11, 2010 |
5 / 5 (1) |
0
Higher co-payments increase chance of early discontinuation of breast cancer therapy
A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive ...
Dec 11, 2010 |
not rated yet |
0
